Invesaro

Stocks IMRX Earnings

Earnings

Immuneering Corp (IMRX) earnings

Quarterly results of Immuneering Corp as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when IMRX files with the SEC.

Next earnings date

Immuneering Corp is expected to report around March 5, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Immuneering Corp reported revenue of - and a net loss of $24.2M.

Diluted earnings per share were -$0.37.

Filed with the SEC on October 29, 2026.

Net income by quarter
Q4 24: -$18.1M -$18.1M Q4 24Q1 25: -$15M -$15M Q1 25Q2 25: -$14.4M -$14.4M Q2 25Q3 25: -$15M -$15M Q3 25Q4 25: -$11.6M -$11.6M Q4 25Q1 26: -$13.5M -$13.5M Q1 26Q2 26: -$17.3M -$17.3M Q2 26Q3 26: -$24.2M -$24.2M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026---$24.2M-$0.37
Q2 FY2026June 30, 2026---$17.3M-$0.27
Q1 FY2026March 31, 2026---$13.5M-$0.21
Q4 FY2025December 31, 2025---$11.6M-
Q3 FY2025September 30, 2025---$15M-$0.38
Q2 FY2025June 30, 2025---$14.4M-$0.40
Q1 FY2025March 31, 2025---$15M-$0.42
Q4 FY2024December 31, 2024---$18.1M-

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Immuneering Corp's next earnings date?

Immuneering Corp is expected to report around March 5, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Get an email when IMRX reports

Follow IMRX and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when IMRX files with the SEC.

Source: quarterly figures Immuneering Corp tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Immuneering Corp